Show simple item record

dc.contributor.authorNguyen, L T T
dc.contributor.authorRoman, Federico 
dc.contributor.authorMorikawa, K
dc.contributor.authorTrincado, Pilar 
dc.contributor.authorMarcos-Moreno, Maria del Carmen 
dc.contributor.authorRojo-Martín, M D
dc.contributor.authorCafini, F
dc.date.accessioned2020-06-02T10:25:25Z
dc.date.available2020-06-02T10:25:25Z
dc.date.issued2018
dc.identifier.citationInt J Antimicrob Agents. 2018 Aug;52(2):305-306es_ES
dc.identifier.issn0924-8579es_ES
dc.identifier.urihttp://hdl.handle.net/20.500.12105/10254
dc.description.abstractAs a consequence of the dissemination of methicillin-resistant Staphylococcus aureus (MRSA) strains and the accumulation of several resistant traits, only a few antibiotics such as vancomycin or linezolid are considered as the last resort antibiotics for the treatment of these strains. The finding of a transferable chloramphenicol/florphenicol resistance (cfr) gene, related to linezolid resistance, has compromised the usage of this antimicrobial in the clinical practice. Although the prevalence of MRSA strains showing resistance to linezolid is still low, hospital outbreaks due to cfr-positive MRSA strains have been documented in Spain [1].es_ES
dc.description.sponsorshipTravel grant was supported by Human Biology Program, School of Integrative and Global Majors, University of Tsukuba (LTTNes_ES
dc.language.isoenges_ES
dc.publisherElsevieres_ES
dc.relation.isversionofPostprintes_ES
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/*
dc.subject.meshChloramphenicol Resistancees_ES
dc.subject.meshGenetic Vectorses_ES
dc.subject.meshHumanses_ES
dc.subject.meshPlasmidses_ES
dc.subject.meshPrevalencees_ES
dc.subject.meshSpaines_ES
dc.subject.meshStaphylococcal Infectionses_ES
dc.subject.meshStaphylococcuses_ES
dc.titlePrevalence of pSCFS7-like vectors among cfr-positive staphylococcal population in Spaines_ES
dc.typeArtículoes_ES
dc.rights.licenseAtribución-NoComercial-CompartirIgual 4.0 Internacional*
dc.identifier.pubmedID29898410es_ES
dc.format.volume52es_ES
dc.format.number2es_ES
dc.format.page305-306es_ES
dc.identifier.doi10.1016/j.ijantimicag.2018.06.004es_ES
dc.description.peerreviewedes_ES
dc.identifier.e-issn1872-7913es_ES
dc.relation.publisherversionhttps://doi.org/10.1016/j.ijantimicag.2018.06.004es_ES
dc.identifier.journalInternational journal of antimicrobial agentses_ES
dc.repisalud.centroISCIII::Centro Nacional de Microbiologíaes_ES
dc.repisalud.institucionISCIIIes_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES


Files in this item

Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail
Acceso Abierto
Thumbnail

This item appears in the following Collection(s)

Show simple item record

Atribución-NoComercial-CompartirIgual 4.0 Internacional
This item is licensed under a: Atribución-NoComercial-CompartirIgual 4.0 Internacional